meet val: a non-hodgkin lymphoma survivor
Published 4 years ago • 1.5K plays • Length 3:34Download video MP4
Download video MP3
Similar videos
-
1:26:11
lymphomas: new treatments, fresh hope
-
39:46
immunotherapy chat w/ drs. andrew zelenetz and lia palomba at memorial sloan kettering cancer center
-
16:39
iwnhl 2015 roundtable: the changing treatment landscape for non-hodgkin lymphoma
-
3:04
mentorship at gerstner sloan kettering: meet ryan and viviane
-
1:55
updated 3-year findings of echelon-1 trial presented for classical hodgkin lymphoma
-
5:56
phase ib shows pembrolizumab elicits complete or partial remission in hodgkin lymphoma
-
12:46
panel discussion on large cell lymphomas: subtypes, patient selection and mutations
-
5:27
is allo-sct still relevant in the immuno-oncology era for hodgkin lymphoma?
-
55:05
science spotlight lecture: marcel van den brink, md, phd | memorial sloan kettering
-
5:11
the aethera trial: risk of progression following asc transplant for hodgkin lymphoma
-
26:20
2016 msk alumni conference - alison moskowitz, md
-
8:50
brentuximab vedotin in treatment naïve chl patients: a 5-year update of the echelon-1 trial
-
2:48
how is the landscape of hodgkin lymphoma therapy changing?
-
3:09
novel strategies emerging for elderly patients with dlbcl and ongoing trials in this space
-
0:44
dr. hamlin on brentuximab vedotin pharmacology
-
1:37
chronos-3: copanlisib plus rituximab for relapsed inhl
-
3:42
trial results of venetoclax plus chop therapy with rituximab or obinutuzumab in non-hodgkin lymphoma
-
23:08
episode 4: understanding the cost of care